John Hancock Municipal Securities Trust has recently filed its NPORT-P report, providing key insights into its financial performance and asset allocation as of August 31, 2026. This filing is significant as it highlights the trust's total assets of approximately $261 million and net assets of about $253 million.
The report indicates that the trust has total liabilities amounting to approximately $7.89 million. This financial snapshot is crucial for investors and stakeholders who are interested in understanding the trust's current standing and future potential.
Background
John Hancock Municipal Securities Trust, an investment entity based in Boston, Massachusetts, is focused on municipal securities. The trust is registered under the SEC file number 811-05968. It has undergone several name changes in its history, including its previous names, Hancock John Municipal Securities Trust and Hancock John Tax Free Bond Trust.
What the Filing Says
The NPORT-P filing, dated October 29, 2026, details the financial status of the trust as of August 31, 2026. The report states, "Total assets are reported at $261,025,239.97, with net assets at $253,131,172.03." This reflects the trust's ongoing commitment to maintaining a robust financial position.
Impact
This update may affect investors and stakeholders in the municipal securities sector, as it provides a clear picture of the trust's financial health. The report's details on asset allocation and performance metrics will be of particular interest to current and potential investors, as well as analysts monitoring the municipal securities market.
What's Next
The filing does not say what happens next, leaving stakeholders to await further updates or filings that may provide additional insights into the trust's future strategies and performance.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






